Alexis Osseni

7PUBLICATIONS
32CO-AUTHORS
Neurology and neuromuscular diseasesMedical infection agents (incl. prions)Predictive and prognostic markersGene and molecular therapyEnergy generation, conversion and storage (excl. chemical and electrical)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 17, 2026
NuMA1 controls myonuclear motility in striated skeletal muscle through AMPK activity and is impaired in Duchenne muscular dystrophy.

|Apr 28, 2025
Muscle mTOR controls iron homeostasis and ferritinophagy via NRF2, HIFs and AKT/PKB signaling pathways.

Agnès Conjard-Duplany, Alexis Osseni, Aline Lamboux

|Feb 13, 2025
Enhanced secretion of the amyotrophic lateral sclerosis ALS-associated misfolded TDP-43 mediated by the ER-ubiquitin specific peptidase USP19.

Flavien Picard, Takashi Nonaka, Edwige Belotti

|Dec 16, 2024
Targeting histone deacetylase 6 (HDAC6) in Duchenne muscular dystrophy: New insights into therapeutic potential.

Alexis Osseni, Laurent Schaeffer

|Nov 19, 2022
Pharmacological inhibition of HDAC6 improves muscle phenotypes in dystrophin-deficient mice by downregulating TGF-β via Smad3 acetylation.

Alexis Osseni, Aymeric Ravel-Chapuis, Edwige Belotti

|Jul 31, 2021
The ESCRT-0 subcomplex component Hrs/Hgs is a master regulator of myogenesis via modulation of signaling and degradation pathways.

L Coudert, A Osseni, Y G Gangloff

Pageof 2

Frequent Collaborators

5 joint publications

Laurent Schaeffer

3 joint publications

Yann-Gaël Gangloff

3 joint publications

Pascal Leblanc

2 joint publications

Agnès Conjard-Duplany